
| Designation | Consultant Nephrologist — Glomerular Disease Subspecialty |
| Qualifications | MBBS · MD (General Medicine) · DM (Nephrology) |
| Subspecialty focus | Glomerular disease — the KIMS nephrologist with specific subspecialty expertise in immune-mediated kidney conditions. Lead nephrologist for kidney biopsy performance and glomerular disease classification. |
| Clinical expertise | IgA nephropathy · Membranous nephropathy · FSGS · Minimal change disease · Lupus nephritis (ISN/RPS classification) · ANCA vasculitis · Anti-GBM disease · Rapidly progressive glomerulonephritis (RPGN) · Nephrotic syndrome · Kidney biopsy |
| OP Timings | Mon – Sat · 9:00 AM – 5:00 PM |
| Book appointment | 040 - 44885000 · assistance@kimshospitals.com |
Dr. Aswini Dutt T is the KIMS nephrologist with specific subspecialty expertise in glomerular disease — the immune-mediated and inflammatory conditions of the kidney's filtering units (glomeruli) that cause proteinuria, haematuria, and progressive kidney damage. Among the KIMS nephrology team, Dr. Aswini Dutt leads the evaluation and management of complex glomerulonephritis subtypes, nephrotic syndrome, and autoimmune kidney disease — conditions that require not only DM Nephrology training but a specific clinical focus accumulated through seeing large numbers of glomerular disease cases.
Glomerular disease diagnosis requires kidney biopsy followed by specialist interpretation of the three-component pathological workup — light microscopy, immunofluorescence, and electron microscopy. Dr. Aswini Dutt performs and interprets kidney biopsies at KIMS, where the NABL-accredited laboratory provides all three components in-house. For conditions where delayed diagnosis costs kidney function — particularly RPGN from ANCA vasculitis, anti-GBM disease, or immune complex nephritis — Dr. Aswini Dutt's ability to arrange emergency biopsy within 24 hours and initiate treatment immediately is a critical clinical capability.
The breadth of Dr. Aswini Dutt's glomerular disease expertise spans the full classification: IgA nephropathy (the world's most common primary glomerulonephritis), membranous nephropathy (now subclassified by PLA2R and THSD7A antibodies into primary and secondary causes with different treatment implications), FSGS (steroid-resistant cases now managed with calcineurin inhibitors and rituximab), lupus nephritis (classified by WHO/ISN-RPS class with treatment intensity matched to the class), and ANCA-associated vasculitis (managed with cyclophosphamide or rituximab induction and azathioprine maintenance).